Skip to main content

Table 2 Mean percentage of lymphocyte subsets at presentation with acute non-complicated malaria, 4 weeks post-recovery and in healthy age-matched controls

From: Alterations on peripheral B cell subsets following an acute uncomplicated clinical malaria infection in children

Cell type Acute
(A)
Recovery
(R)
Controls
(C)
Significance
mean (SEM)
percent
mean (SEM)
percent
mean (SEM)
percent
A vs.R A vs.C R vs.C
CD3+CD45+ 56.9 (2.4) 54.3 (2.3) 52.7 (2.7) 0.37 0.27 0.67
CD19+CD45+ 21.4 (2.1) 26.1 (1.7) 23.5 (2.8) 0.02 0.53 0.41
CD4+CD3+ 34.8 (2.6) 36.0 (2.2) 29.4 (1.9) 0.64 0.14 0.04
CD8+CD3+ 16.0 (2.5) 12.8 (1.2) 18.2 (0.8) 0.22 0.62 0.03
Naive 1
CD38-IgD+CD19+
23.7 (2.9) 29.3 (4.2) 38.2 (3.4) 0.03 0.00 0.12
Naive 2
CD38+IgD+CD19+
39.7 (3.8) 44.7 (4.4) 27.2 (4.4) 0.11 0.04 0.01
Memory 3
CD38+IgD-CD19+
22.7 (2.4) 14.4 (1.3) 14.2 (1.1) 0.00 0.01 0.91
Memory 4
CD38-IgD-CD19+
13.5 (1.4) 11.7 (1.3) 22.8 (2.6) 0.11 0.01 0.00
CD10+CD19+ 24.6 (2.5) 29.0 (2.7) 21.2 (1.8) 0.04 0.31 0.04
  1. Sample size (n) was n = 15 for all Acute & Recovery outcomes except CD19+CD10+ (n = 12), and all Memory and Naive outcomes (n = 11). N = 11 for controls except for CD4 (n = 10), CD19+CD10+ (n = 9), CD19+CD27+ (n = 7), and CD8 (n = 5). Heterogeneity of variance assumptions were tested by the Levene statistic, and heterogeneous t-tests were utilized as needed. Significant differences are in bold.